The price of febiflu, a heavy power drug used in the treatment of Corona patients in the country, has been cut by 27 percent. The pharmaceutical company Glenmark Pharmaceuticals has decided to cut antiviral drug prices. Now the patients will get this tablet at a price of Rs 75.

The drug company launched this drug last month and it was priced at Rs 103. The company says that the price of the drug has been cut because of its sales and profits on a large scale. Let us know that this drug has been prepared in India in a complete manner.

Pharmaceutical company Glenmark says that these drugs are being sold in India at cheaper rates than other countries. The company's business head Alok Malik says that the price of the medicine is expected to benefit Kovid-19 patients across the country.

Explain that the same drug is being sold at an average of Rs 600 in Russia, Rs 378 in Japan, Rs 350 in Bangladesh, and Rs 215 per tablet in China. Alok Malik said that the company has studied it on a thousand patients to test the effect of the drug.

This study will reveal better information about the effect of the drug. The company has completed a Phase III trial of the drug on moderate to average patients, the results of which will come soon. The company said that in addition to this, two more antiviral drugs, favipiravir, and amprenavir, are being tested in Phase III on simultaneous patients.